Patents by Inventor Olivier Colliou
Olivier Colliou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230147605Abstract: An unobtrusive ambulatory wearable biosensor device, system, and method continuously monitors blood oxygen saturation of a patient in their free-living conditions. The wearable biosensor system may include a finger sensor device, wrist module device, relay device, and wearable sensor patch.Type: ApplicationFiled: November 5, 2021Publication date: May 11, 2023Inventors: Nersi Nazari, Olivier Colliou, Wenkang Qi
-
Publication number: 20220323364Abstract: Controlled activation identifiers for use in ingestible compositions, such as pharma-informatics enabled compositions, are provided. The identifiers include a controlled activation element that provides for activation of the identifier in response to the presence of a predetermined stimulus at a target site of interest. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc.Type: ApplicationFiled: May 10, 2022Publication date: October 13, 2022Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Hooman Hafezi, Timothy Robertson, Olivier Colliou, Mark Zdeblick
-
Patent number: 11357730Abstract: Apparatuses for use with a pharmaceutically acceptable carrier. The apparatus can include a partial power source, which in turn includes electrodes or materials that are configured to generate an electrical potential upon contacting or being exposed to an ionic solution. The apparatus can further include a circuit electrically or communicatively coupled to the partial power source. The circuit can generate various types of signals, such as RF signals, when powered by the partial power source. The circuit is stably fittable to the pharmaceutically acceptable carrier. The apparatus can further include a barrier, a protective layer, or a membrane that isolates the electrodes or materials from the ionic solution and is configured to be dissolved by the ionic solution.Type: GrantFiled: December 28, 2018Date of Patent: June 14, 2022Assignee: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Hooman Hafezi, Timothy Robertson, Olivier Colliou, Mark Zdeblick
-
Patent number: 11185287Abstract: A device-securing overlay includes a wearable strip that has a controlled applicant to fit over at least a portion of a wearable device, while an adhesive on an under portion of the wearable strip is placed in contact with at least a top portion of an outer rim of the wearable device as well as a surface upon which the wearable device is placed, without covering portions of the wearable device that require ventilation or an unobstructed view.Type: GrantFiled: June 22, 2018Date of Patent: November 30, 2021Assignee: Vital Connect, Inc.Inventors: Olivier Colliou, Rod Moghadam
-
Patent number: 10856741Abstract: A system and method for detecting and monitoring core body temperature are disclosed. The system includes a patch device and an electronic module coupled to the patch device. The method includes providing a patch device, coupling an electronic module to the patch device to provide a wearable device, and monitoring core body temperature of a user using the wearable device.Type: GrantFiled: December 14, 2016Date of Patent: December 8, 2020Assignee: Vital Connect, Inc.Inventors: Dhwanil Damania, Olivier Colliou, Arshan Aga
-
Patent number: 10517506Abstract: Low profile antennas for ingestible devices, such as ingestible event markers, are provided. Aspects of the ingestible devices of the invention include low profile signal transmission antennas configured such that they are flexible or degrade after use, allowing the antenna and attached components to pass easily through the body. Embodiments of the low profile antennas are configured to emit a detectable signal upon contact with a target physiological site. Also provided are methods of making and using the devices of the invention.Type: GrantFiled: May 6, 2013Date of Patent: December 31, 2019Assignee: Proteus Digital Health, Inc.Inventors: Timothy L. Robertson, Olivier Colliou, Eric J. Snyder, Mark Zdeblick
-
Publication number: 20190388030Abstract: A device-securing overlay includes a wearable strip that has a controlled applicant to fit over at least a portion of a wearable device, while an adhesive on an under portion of the wearable strip is placed in contact with at least a top portion of an outer rim of the wearable device as well as a surface upon which the wearable device is placed, without covering portions of the wearable device that require ventilation or an unobstructed view.Type: ApplicationFiled: June 22, 2018Publication date: December 26, 2019Inventors: Olivier Colliou, Rod Moghadam
-
Publication number: 20190261888Abstract: A re-wearable wireless device configured to be attached to a user is disclosed. In some embodiments, the re-wearable wireless device includes a disposable component and a reusable component. The disposable component may include a first electrode, a second electrode, a cradle, and a battery. The cradle may include a first electrical connector, wherein the first electrical connector is electrically coupled to the first electrode, the second electrode, and the battery. The reusable component may include an electronics module, a housing configured to latch into the cradle, a second electrical connector, wherein the second electrical connector electrically couples the reusable component to the first electrode, the second electrode, and the battery. The re-wearable wireless device may be configured to detect a conductive electrical signal through the first electrode and the second electrode.Type: ApplicationFiled: May 7, 2019Publication date: August 29, 2019Inventors: Mark Zdeblick, Kien Lam, Jeremy Frank, Robert Azevedo, Elizabeth Klein, David O'Reilly, Aditya Dua, Joan Hain, Robert Leichner, Christopher Reggiardo, Lawrence Arne, Arna Ionescu Stoll, Kristin Pollock, Olivier Colliou, James Fish
-
Publication number: 20190133958Abstract: Apparatuses for use with a pharmaceutically acceptable carrier. The apparatus can include a partial power source, which in turn includes electrodes or materials that are configured to generate an electrical potential upon contacting or being exposed to an ionic solution. The apparatus can further include a circuit electrically or communicatively coupled to the partial power source. The circuit can generate various types of signals, such as RF signals, when powered by the partial power source. The circuit is stably fittable to the pharmaceutically acceptable carrier. The apparatus can further include a barrier, a protective layer, or a membrane that isolates the electrodes or materials from the ionic solution and is configured to be dissolved by the ionic solution.Type: ApplicationFiled: December 28, 2018Publication date: May 9, 2019Inventors: Hooman Hafezi, Timothy Robertson, Olivier Colliou, Mark Zdeblick
-
Patent number: 10238604Abstract: Controlled activation identifiers for use in ingestible compositions, such as pharma-informatics enabled compositions, are provided. The identifiers include a controlled activation element that provides for activation of the identifier in response to the presence of a predetermined stimulus at a target site of interest. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc.Type: GrantFiled: December 15, 2014Date of Patent: March 26, 2019Assignee: Proteus Digital Health, Inc.Inventors: Hooman Hafezi, Timothy Robertson, Olivier Colliou, Mark Zdeblick
-
Publication number: 20180160909Abstract: A system and method for detecting and monitoring core body temperature are disclosed. The system includes a patch device and an electronic module coupled to the patch device. The method includes providing a patch device, coupling an electronic module to the patch device to provide a wearable device, and monitoring core body temperature of a user using the wearable device.Type: ApplicationFiled: December 14, 2016Publication date: June 14, 2018Inventors: Dhwanil Damania, Olivier Colliou, Arshan Aga
-
Patent number: 9439599Abstract: A body associated device comprises a housing, an adhesive layer configured to be applied to a body of a living subject, and at least one standoff located between the housing and the adhesive layer. An electronic module may be located within the housing of the body associated device. A personal communication system comprises a body associated device including an electronic module and further comprises a feedback portion coupled to the housing and to the electronic module. The feedback portion is configured to communicate information between the living subject and the body associated device. An external local node is operative to provide at least one of transmit communications to and receive communications from the body associated device.Type: GrantFiled: March 8, 2012Date of Patent: September 13, 2016Assignee: Proteus Digital Health, Inc.Inventors: Todd Thompson, Olivier Colliou, Robert Duck, Yashar Behzadi
-
Publication number: 20150182463Abstract: Controlled activation identifiers for use in ingestible compositions, such as pharma-informatics enabled compositions, are provided. The identifiers include a controlled activation element that provides for activation of the identifier in response to the presence of a predetermined stimulus at a target site of interest. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc.Type: ApplicationFiled: December 15, 2014Publication date: July 2, 2015Inventors: Hooman Hafezi, Timothy Robertson, Olivier Colliou, Mark Zdeblick
-
Patent number: 8945005Abstract: Controlled activation identifiers for use in ingestible compositions, such as pharma-informatics enabled compositions, are provided. The identifiers include a controlled activation element that provides for activation of the identifier in response to the presence of a predetermined stimulus at a target site of interest. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc.Type: GrantFiled: October 25, 2007Date of Patent: February 3, 2015Assignee: Proteus Digital Health, Inc.Inventors: Hooman Hafezi, Timothy Robertson, Olivier Colliou, Mark Zdeblick
-
Patent number: 8932221Abstract: Multi-directional transmitters for in-body devices, such as implantable and ingestible devices, are provided. Aspects of the in-body multi-direction transmitters of the invention include signal transmitters configured to transmit an identifying signal in at least two different directions in an x-y plane. Embodiments of the in-body devices are configured to emit a detectable signal upon contact with a target physiological site. Also provided are methods of making and using the devices of the invention.Type: GrantFiled: March 7, 2008Date of Patent: January 13, 2015Assignee: Proteus Digital Health, Inc.Inventors: Olivier Colliou, Timothy Robertson, Mark Zdeblick
-
Publication number: 20140206976Abstract: A body associated device comprises a housing, an adhesive layer configured to be applied to a body of a living subject, and at least one standoff located between the housing and the adhesive layer. An electronic module may be located within the housing of the body associated device. A personal communication system comprises a body associated device including an electronic module and further comprises a feedback portion coupled to the housing and to the electronic module. The feedback portion is configured to communicate information between the living subject and the body associated device. An external local node is operative to provide at least one of transmit communications to and receive communications from the body associated device.Type: ApplicationFiled: March 8, 2012Publication date: July 24, 2014Applicant: PROTEUS DIGITAL HEALTH, INC.Inventors: Todd Thompson, Olivier Colliou, Robert Duck, Yashar Behzadi
-
Publication number: 20140180202Abstract: An ingestible therapy activator system and method are provided. In one aspect, the ingestible therapy activator includes an ingestible device having an effector module to send an effector instruction and a responder module associated with a therapeutic device. The responder module may receive and process the effector instruction, resulting in a response by the therapeutic device. Examples of responses by therapeutic device include activating a therapy, deactivating a therapy, modulating a therapy, and discontinuing a therapy.Type: ApplicationFiled: February 26, 2014Publication date: June 26, 2014Applicant: Proteus Digital Health, Inc.Inventors: MARK ZDEBLICK, MARC JENSEN, OLIVIER COLLIOU, ANGELA STRAND
-
Patent number: 8738154Abstract: Implantable stimulation devices are provided. Aspects of the devices include a multiplexed multi-electrode component configured for neural stimulation. The multiplexed multi-electrode component includes two or more individually addressable satellite electrode structures electrically coupled to a common conductor. The satellite structures include a hermetically sealed integrated circuit controller operatively coupled to one or more electrodes. Also provided are systems that include the devices of the invention, as well as methods of using the systems and devices in a variety of different applications.Type: GrantFiled: May 24, 2011Date of Patent: May 27, 2014Assignee: Proteus Digital Health, Inc.Inventors: Mark Zdeblick, Todd Thompson, Marc Jensen, Olivier Colliou, Angela Strand
-
Patent number: 8583227Abstract: Portable electroviscerography systems are provided. Aspects of the systems include a body-associated receiver and an ingestible identifier unit, both of which are configured to detect visceral electrical signals. The system communicates with an extra-corporeal data processor configured to receive data from the body-associated receiver and generate and electroviscerogram from the received data. Also provided are methods of producing electroviscerograms using systems of the present invention.Type: GrantFiled: September 23, 2011Date of Patent: November 12, 2013Assignee: Proteus Digital Health, Inc.Inventors: George Savage, Hooman Hafezi, Olivier Colliou, Mark Zdeblick, Angela Strand
-
Patent number: 8540632Abstract: Low profile antennas for ingestible devices, such as ingestible event markers, are provided. Aspects of the ingestible devices of the invention include low profile signal transmission antennas configured such that they are flexible or degrade after use, allowing the antenna and attached components to pass easily through the body. Embodiments of the low profile antennas are configured to emit a detectable signal upon contact with a target physiological site. Also provided are methods of making and using the devices of the invention.Type: GrantFiled: May 23, 2008Date of Patent: September 24, 2013Assignee: Proteus Digital Health, Inc.Inventors: Timothy L. Robertson, Olivier Colliou, Eric Snyder, Mark J. Zdeblick